Brief: Revolution Medicines Inc Files For Common Stock Offering Of Up To $1.0 Billion
Feb 25 (Reuters) - Revolution Medicines Inc RVMD.O: REVOLUTION MEDICINES INC FILES FOR COMMON STOCK OFFERING OF UP TO $1.0 BILLION - SEC FILING Further company coverage: RVMD.O ((Reuters.Briefs@thomsonreuters.com;))
Recent news on Revolution Medicines
See all newsAnalysis: Revolution Medicines' Europe efforts signal solo launch ambitions for cancer drug
Brief: CHMP Recommends Granting Marketing Authorisation For Rasonque For Metastatic Pancreatic Cancer In EU
Revolution Medicines wins EU committee backing for pancreatic cancer treatment (updated)
EMA recommends approval of Revolution's pancreatic cancer drug
Revolution Medicines falls on pancreatic cancer drug data concerns